However, they reported a strange data about the plasma IL-17 level in AML patients, explaining that plasma IL-17 level was significantly decreased in newly-diagnosed AML patients with non-complete remission or complete remission compared with healthy subjects.        95  In another study Han et al. demonstrated that the frequency of Th17 cells was significantly increased in bone marrow mononuclear cells and PBMCs from AML patients compared with healthy donors. Here, IL17A is linked to acute myeloid leukemia.